Antlia Bioscience, Inc.
Developing novel long-acting therapeutics targeting chronic cardiometabolic diseases.
Funding history
About Antlia Bioscience, Inc.
How much funding has Antlia Bioscience, Inc. raised?
Antlia Bioscience, Inc. has raised $6.0M in total funding. The most recent round was Seed.
Where is Antlia Bioscience, Inc. headquartered?
Antlia Bioscience, Inc. is headquartered in Encinitas, CA.
What does Antlia Bioscience, Inc. do?
Developing novel long-acting therapeutics targeting chronic cardiometabolic diseases.
What's Antlia Bioscience, Inc.'s solution?
Antlia Bioscience develops novel long-acting therapeutics targeting chronic cardiometabolic diseases.
What makes Antlia Bioscience, Inc. notable?
Founded in 2020 by Brian Johnson and Nigel Shankley, the San Diego biopharma has raised roughly $6.2M developing long-acting peptide therapies for cardiometabolic disease.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
